Milestone Pharmaceuticals USA Inc.
Milestone Pharmaceuticals USA Inc.
Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions.
Company Location
6210 Ardrey Kell Road, Suite 650
Charlotte
NC
28277
Phone
County
Region
Company Details
Company type
Year founded
2005
Employment range in NC
US headquarters
North Carolina
Global headquarters
Canada
Primary site activity
All company activities
Products under development
Etripamil